Literature DB >> 7166181

The metabolism of nicotine-delta 1'(5')-iminium ion, in vivo and in vitro.

J W Gorrod, A R Hibberd.   

Abstract

Nicotine-delta 1'(5')-iminium ion, either as the diperchlorate or the hydrochloride, is rapidly converted into cotinine by a hepatic cytoplasmic enzyme. Incubations in an atmosphere of nitrogen indicated that the oxygen incorporated into cotinine is derived from water. Following the intraperitoneal administration of nicotine-delta 1'(5')-iminium ion to guinea pigs or rats, cotinine, and nicotine-1'-N-oxide were found in the urine. The results support the idea that nicotine-delta 1'-(5')-iminium ion is an intermediate in the metabolic conversion of nicotine to cotinine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7166181     DOI: 10.1007/BF03189632

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  Enzymatic pathway for the formation of cotinine, a major metabolite of nicotine in rabbit liver.

Authors:  H B HUCKER; J R GILLETTE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1960-05       Impact factor: 4.030

2.  The metabolism of N-ethyl-N-methylaniline by rabbit liver microsomes: the measurement of metabolites by gas-liquid chromatography.

Authors:  J W Gorrod; D J Temple; A H Beckett
Journal:  Xenobiotica       Date:  1975-08       Impact factor: 1.908

3.  The analysis of nicotine-1'-N-oxide in urine, in the presence of nicotine and cotinine, and its application to the study of in vivo nicotine metabolism in man.

Authors:  A H Beckett; J W Gorrod; P Jenner
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

4.  The effect of smoking on nicotine metabolism in vivo in man.

Authors:  A H Beckett; J W Gorrod; P Jenner
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

5.  Factors affecting the in vitro metabolism of R-(+)- and S-(-)-nicotine by guinea-pig liver preparations.

Authors:  P Jenner; J W Gorrod; A H Beckett
Journal:  Xenobiotica       Date:  1973-09       Impact factor: 1.908

6.  Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite.

Authors:  D L Hill; W R Laster; R F Struck
Journal:  Cancer Res       Date:  1972-04       Impact factor: 12.701

7.  Selective inhibition of alternative oxidative pathways of nicotine metabolism.

Authors:  J W Gorrod; P Jenner; G Keysell; A H Beckett
Journal:  Chem Biol Interact       Date:  1971-08       Impact factor: 5.192

8.  An improved preparation of tertiary amine N-oxides.

Authors:  J Cymerman Craig; K K Purushothaman
Journal:  J Org Chem       Date:  1970-05       Impact factor: 4.354

9.  Enzymatic oxidation of nicotine to nicotine 1'(5') iminium ion. A newly discovered intermediate in the metabolism of nicotine.

Authors:  P J Murphy
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

10.  Species variation in the metabolism of R-(+)- and S-(-)-nicotine by alpha-C- and N-oxidation in vitro.

Authors:  P Jenner; J W Gorrod; A H Beckett
Journal:  Xenobiotica       Date:  1973-09       Impact factor: 1.908

  10 in total
  11 in total

1.  Catalytic mechanism of cytochrome P450 for 5'-hydroxylation of nicotine: fundamental reaction pathways and stereoselectivity.

Authors:  Dongmei Li; Xiaoqin Huang; Keli Han; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2011-04-22       Impact factor: 15.419

2.  Fundamental reaction pathways for cytochrome P450-catalyzed 5'-hydroxylation and N-demethylation of nicotine.

Authors:  Dongmei Li; Yong Wang; Keli Han; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2010-07-15       Impact factor: 2.991

Review 3.  Aspects of the oxidative metabolism of nicotine.

Authors:  G B Neurath
Journal:  Clin Investig       Date:  1994-02

4.  Nicotine exposure and metabolizer phenotypes from analysis of urinary nicotine and its 15 metabolites by LC-MS.

Authors:  Kannan Rangiah; Wei-Ting Hwang; Clementina Mesaros; Anil Vachani; Ian A Blair
Journal:  Bioanalysis       Date:  2011-04       Impact factor: 2.681

5.  Metabolism of (-)-(S)-nicotine in the isolated perfused rabbit lung.

Authors:  G Aislaitner; A Bello; S C Tan; A J Hutt; C Marriott; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

6.  CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Δ5'(1')iminium ion.

Authors:  Linda B von Weymarn; Cassandra Retzlaff; Sharon E Murphy
Journal:  J Pharmacol Exp Ther       Date:  2012-08-06       Impact factor: 4.030

7.  Catalytic mechanism of cytochrome P450 for N-methylhydroxylation of nicotine: reaction pathways and regioselectivity of the enzymatic nicotine oxidation.

Authors:  Dongmei Li; Xiaoqin Huang; Jianping Lin; Chang-Guo Zhan
Journal:  Dalton Trans       Date:  2013-01-09       Impact factor: 4.390

Review 8.  The metabolism of alicyclic amines to reactive iminium ion intermediates.

Authors:  J W Gorrod; G Aislaitner
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

9.  PPARα agonist WY-14,643 enhances ethanol metabolism in mice: Role of catalase.

Authors:  Xue Chen; Yunhui Xu; Krista L Denning; Audrey Grigore; Yongke Lu
Journal:  Free Radic Biol Med       Date:  2021-04-20       Impact factor: 8.101

10.  Identification of CYP 2A6 inhibitors in an effort to mitigate the harmful effects of the phytochemical nicotine.

Authors:  Navneet Goyal; Jayalakshmi Sridhar; Camilla Do; Melyssa Bratton; Shahensha Shaik; Quan Jiang; Maryam Foroozesh
Journal:  J Cancer Metastasis Treat       Date:  2021-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.